NASDAQ
Revance Therapeutics, Inc. (RVNC) has a interest coverage ratio of -16.37x as of Wednesday, July 15, 2026. This represents a 16.44% increase compared to its 12-month average of -19.59x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.